BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY
BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY
批准号:
7952072
负责人:
ROBIN K OHLS
金额:
$8.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30
关键词:
AdultAgeAntibioticsBiological MarkersBloodChildClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseDiagnosisDropsFundingGermGrantHandInfantInfectionInstitutionLaboratoriesLifeMethodsNatureNeonatal Intensive Care UnitsNew MexicoNewborn InfantOrganismPharmaceutical PreparationsPopulationPremature InfantRecoveryRecurrenceResearchResearch PersonnelResistance developmentResourcesRiskSepsisSourceSymptomsTestingTimeUnited States National Institutes of HealthUniversitiesVery Low Birth Weight Infantantimicrobial drugexperienceneonatal sepsispreventresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Bacterial blood infection is a frequent and serious problem in neonatal intensive care units, particularly in very low birth weight infants. Diagnosis by blood culture is difficult, time consuming, and lacks sensitivity. Over 20% of all very low birth weight infants experience one or more episodes of late onset sepsis [defined as any sepsis occurring after 3 days of age]. The median age for the first episode of late onset sepsis is 17 days. Delaying treatment until symptoms arise can be life threatening. On the other hand, recurrent treatment with antimicrobial agents in infants that are not infected holds potential risks to these infants by furthering the development of resistant organisms. This therefore, is an ideal population to evaluate to develop a rapid and sensitive product to identify infection.
Newborns [especially premature infants or those with very low birth weight] are at much greater risk for life-threatening infections than older children and adults. Diagnosing these infections is difficult with current laboratory methods. Because of the life-threatening nature of these infections, infants in the Newborn Intensive Care Unit [NICU] are almost always placed on powerful antibiotics until we can confirm whether or not an infection is truly present. While these medications are necessary, using them too frequently can cause germs to develop resistance, which prevents the antibiotics from being effective.
The purpose of this research study is to investigate a new laboratory method of diagnosing infections in newborns using a single drop of blood. From this small amount of blood we can test for markers of infection. We will be looking for markers that would suggest that an infant is infected. We intend to compare these tests with current methods in order to find out if we can diagnose serious infections more quickly. This may allow us to avoid treating infants with antibiotics when they are not needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
-
批准号:10152693
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2019
-
负责人:ROBIN K OHLS
-
依托单位:
Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC
-
批准号:9899664
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2019
-
负责人:ROBIN K OHLS
-
依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
-
批准号:9899864
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2016
-
负责人:ROBIN K OHLS
-
依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
-
批准号:10682083
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2016
-
负责人:ROBIN K OHLS
-
依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
-
批准号:10352220
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2016
-
负责人:ROBIN K OHLS
-
依托单位:
NICHD Cooperative Multicenter Neonatal Research Network - Utah Center
-
批准号:10348097
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2016
-
负责人:ROBIN K OHLS
-
依托单位:
Brain imaging and developmental follow-up of infants treated with erythropoietin
-
批准号:8055990
-
项目类别:
-
资助金额:$47.15万
-
财政年份:2010
-
负责人:ROBIN K OHLS
-
依托单位:
Brain imaging and developmental follow-up of infants treated with erythropoietin
-
批准号:8442914
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2010
-
负责人:ROBIN K OHLS
-
依托单位:
Brain imaging and developmental follow-up of infants treated with erythropoietin
-
批准号:8225236
-
项目类别:
-
资助金额:$41.51万
-
财政年份:2010
-
负责人:ROBIN K OHLS
-
依托单位:
Brain imaging and developmental follow-up of infants treated with erythropoietin
-
批准号:8616082
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2010
-
负责人:ROBIN K OHLS
-
依托单位:
Brain imaging and developmental follow-up of infants treated with erythropoietin
-
批准号:7899366
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2010
-
负责人:ROBIN K OHLS
-
依托单位:
A RANDOMIZED, MASKED, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND
-
批准号:8166601
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2009
-
负责人:ROBIN K OHLS
-
依托单位:
BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY
-
批准号:8166611
-
项目类别:
-
资助金额:$2.55万
-
财政年份:2009
-
负责人:ROBIN K OHLS
-
依托单位:
A RANDOMIZED, MASKED STUDY OF WEEKLY ERYTHOPOIETIN DOSING
-
批准号:8166598
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2009
-
负责人:ROBIN K OHLS
-
依托单位:
A RANDOMIZED, MASKED, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND
-
批准号:7952055
-
项目类别:
-
资助金额:$10.57万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
A RANDOMIZED, MASKED, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND
-
批准号:7716596
-
项目类别:
-
资助金额:$5.69万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
RANDOMIZED CLINICAL TRIAL OF INHALED PGE, IN NEONATAL HYPOXEMIC RESPIRATORY
-
批准号:7952087
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
A RANDOMIZED DOSE-RESPONSE STUDY TO ASSESS THE SAFETY AND PRELIMINARY EFFICACY
-
批准号:7952036
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
CLINICAL TRIAL: A RANDOMIZED DOSE-RESPONSE STUDY TO ASSESS THE SAFETY AND PRELIM
-
批准号:7716568
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
BIOMARKER PROFILES AS PREDICATORS OF NEONATAL SEPSIS AND RECOVERY
-
批准号:7716617
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2008
-
负责人:ROBIN K OHLS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: